The protein kinase, GSK-3, participates in diverse biological processes and is now
recognized a promising drug discovery target in treating multiple pathological conditions …

Neurodegenerative disorders are spreading worldwide and are one of the greatest threats to
public health. There is currently no adequate therapy for these disorders, and therefore there …

Sepsis-associated encephalopathy (SAE) is commonly defined as diffuse brain dysfunction
and can manifest as delirium to coma. Accumulating evidence has suggested that …

Understanding the neural basis of cognitive deficits, a key feature of Alzheimer's disease
(AD), is imperative for achieving the therapy of the disease. Rhythmic oscillatory activities in …

Psychedelic compounds are being increasingly explored as a potential therapeutic option
for treating several psychiatric conditions, despite relatively little being known about their …

Schizophrenia is a heterogeneous psychiatric disorder with a strong genetic basis, whose
etiology and pathophysiology remain poorly understood. Exome sequencing studies have …

Abstract Fragile X Syndrome (FXS) is a leading known genetic cause of intellectual disability
with symptoms that include increased anxiety and social and sensory processing deficits …

Schizophrenia is a serious neuropsychiatric disorder characterized by the presence of
positive symptoms (hallucinations, delusions, and disorganization of thought and language) …

Blockade of N-methyl-D-aspartate receptors (NMDAR) is known to augment cortical
serotonin 2A receptors (5-HT2ARs), which is implicated in psychosis. However, the …

Increasing evidence indicates that the host immune response has a monumental role in the
etiology of major depressive disorder (MDD), motivating the development of the …